BridgeBio Pharma, Inc. held its Annual Meeting of Stockholders on June 21, 2024, where various proposals were voted upon, including the election of directors, approval of executive compensation, ratification of accounting firm appointment, and approval of an amendment to the stock option and incentive plan.